A Study on Etiological Pathophysiology and Management of Epilepsy
Main Article Content
Abstract
Hippocrates was the among the earliest who discovered epilepsy and suggest that is hereditary rather than contagious. Epilepsy is a disorder of the brain characterized by repeated seizures. It is usually defined as a sudden alteration of behaviour due to a temporary change in the electrical functioning of the brain. Epilepsy, a disorder of unprovoked seizures is a multifaceted disease affecting individuals of all ages with a particular predilection for the very young and old. In addition to seizures, many patients often report cognitive and psychiatric problems associated with both the seizures themselves and its therapy. Epilepsy has numerous etiologies both idiopathic and acquired with a wide range of therapeutic responses. Despite numerous neuromodulatory devices, a large treatments available to control repetitive seizures including medications, diets, immunotherapy, surgery, and percentage of patients continue to suffer the consequences of uncontrolled seizures, which include psychosocial stigma and death.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon CS, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology
II. Beghi E, Hesdorffer D. Prevalence of epilepsy – an unknown quantity. Epilepsia. 2014 Jul;55(7):963–7.2017 Jan;88(3):296–303.
III. Aird RB. (1983) The importance of seizure-inducing factors in the control of refractory forms of epilepsy. Epilepsia 24:567–583.
IV. Beghi E. (2004) Etiology of epilepsy. In Shorvon SD, Perucca E, Engel J(Eds) The treatment of epilepsy. 2nd ed. Blackwell Science, Oxford, pp. 50–64.
V. Berg A, Berkovic S, Brodie M, Buchhalter J, Cross J, van Emde Boas W, Engel J, French J, Glauser T, Mathern G, Mosh S, Nordli D, Plouin P, Scheffer I. (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51:676–685.
VI. This list is derived from the book Causes of Epilepsy (Shorvon et al., 2011b).
VII. Dreifuss FE. Prevention as it pertains to epilepsy. Arch Neurol. 1995;52(4):363–6.
VIII. Sillanpää M, Gissler M, Schmidt D. Efforts in epilepsy prevention in the last 40 years: lessons from a large nationwide study. JAMA Neurol. 2016;73(4):390–5. An important article showing that we failed to prevent epilepsy in people below age 65 and a massive increase in epilepsy in the elderly.
IX. Freeman JM, Kossoff EH, Hartman AL. Ketogenic diet: One decade later. Pediatrics. 2007;119:535–43.
X. Rajesh B, Jaychandran D, Mohandas G, Radhakrishnan K. A pilot study of yoga meditation protocol for patients with medically refractory epilepsy. J Altern Compliment Med. 2006;12:367–71.
XI. Moharana D, Moharana S. A clinical trial of mentat in patients with various types of epilepsy. Probe. 1994;33:160–2.
XII. Barbara G. Wells, PharmD, FASHP, FCCP Dean Emeritus and Professor Emeritus Executive Director Emeritus, Research Institute of Pharmaceutical Sciences School of Pharmacy, The University of Mississippi Oxford, Mississippi
XIII. Joseph T. DiPiro, PharmD, FCCP Professor and Dean Archie O. McCalley Chair School of Pharmacy Virginia Commonwealth University Richmond, Virginia
XIV. Terry L. Schwinghammer, PharmD, FCCP, FASHP, FAPhA, BCPS Professor and Chair, Department of Clinical Pharmacy School of Pharmacy, West Virginia University Morgantown, West Virginia
XV. Cecily V. DiPiro, PharmD Consultant Pharmacist Richmond, Virginia
XVII. https://www.npr.org/2023/01/19/1149993707/new-tech-gives-hope-for-a-million-people-with-epilepsy